ICD-10 Coding for Mediastinal Adenopathy(C34.90, C77.1, C77.1B)
Comprehensive guide on ICD-10 coding for mediastinal adenopathy, including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Mediastinal Adenopathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R59.0 | Localized enlarged lymph nodes | Use when mediastinal adenopathy is localized and no specific etiology is confirmed. |
|
| C77.1 | Secondary and unspecified malignant neoplasm of mediastinal lymph nodes | Use when mediastinal adenopathy is due to metastasis from a known primary cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMediastinal Adenopathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Mediastinal Adenopathy.
Omitting node size in documentation.
Impact
Clinical: May lead to incorrect treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient documentation.
Mitigation
Train staff on documentation standards., Use templates that prompt for node size.
Coding mediastinal adenopathy as generalized lymphadenopathy.
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure documentation specifies 'mediastinal' and use R59.0 for localized cases.
Unspecified lymphadenopathy coding
Impact
Using R59.9 without sufficient documentation.
Mitigation
Ensure documentation specifies node location and size.